- Q1 2024 Nanobiotix SA Earnings Call TranscriptMay 22, 2024€5.41 (-13.93%)Earnings
- Nanobiotix SA 65th ASTRO Annual Meeting 2023 TranscriptOct 05, 2023
- Half Year 2023 Nanobiotix SA Earnings Call TranscriptSep 27, 2023€8 (+0.38%)Earnings
- Nanobiotix SA at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Nanobiotix SA License Agreement with Janssen Briefing TranscriptJul 10, 2023
- Q4 2022 Nanobiotix SA Earnings Call TranscriptApr 25, 2023€2.5 (-27.26%)Earnings
- Nanobiotix SA at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Nanobiotix SA at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Nanobiotix SA Earnings Call TranscriptNov 10, 2022€3.68 (-1.87%)Earnings
- Q2 2022 Nanobiotix SA Earnings Call TranscriptSep 29, 2022€3.5 (-0.43%)Earnings
- Nanobiotix SA at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Q1 2022 Nanobiotix SA Earnings Call TranscriptMay 19, 2022€5.18 (+0.58%)Earnings
- Q4 2021 Nanobiotix SA Earnings Call TranscriptMar 31, 2022Earnings
Nanobiotix SA License Agreement with Janssen Briefing Transcript
Good day and thank you for standing by. Welcome to the Nanobiotix License Agreement with Janssen Pharmaceutica NV, one of Janssen Pharmaceutical Companies of J&J, for the co-development and commercialization of NBTXR3 conference call. A slide presentation accompanying this call can be found on the investor section of the company's website at www.nanobiotix.com. (Operator Instructions) Please be advised that today's conference is being recorded. At this point, I'll turn the call over to Craig West, Senior Vice President of Investor Relations of Nanobiotix.
Thank you, Melissa. Good afternoon and good morning, everyone, and welcome to the Nanobiotix Conference call to discuss our worldwide agreement with Janssen for the co-development and commercialization of our potentially first-in-class radioenhancer, NBTXR3. By Janssen, we mean Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of J&J. Slides for today's call can be found on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)